AstraZeneca gets CDSCO approval for drug to treat biliary tract cancer

AstraZeneca India announced that it has received approval from the country's drug regulator to market a drug to treat biliary tract cancer (BTC). Durvalumab has been approved by the Central Drugs Standard Control Organisation (CDSCO),...

Lupin's Nagpur facility receives EIR from US FDA

Lupin Limited (Lupin) announced that the United States Food and Drug Administration (US FDA) has approved the Establishment Inspection Report (EIR) for its new injectable facility in Nagpur...

PureTech Health to develop oral allopregnanolone to treat anxiety disorders and postpartum depression

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, announced that it will advance LYT-300 (oral allopregnanolone), a clinical therapeutic candidate in development as...

Aster Pharmacy collaborates with Dr. Reddy's to market its high-quality medicines in UAE and GCC

Aster Pharmacy, the retail arm of Aster DM Healthcare and a leading pharmacy chain in the GCC, and Dr. Reddy's laboratories India Ltd, a global pharmaceutical firm headquartered in Hyderabad, India, have signed a memorandum of understanding to...

Moderna's non-vaccine mRNA therapeutic set to generate $278 million in 2028

GlobalData, a data analytics firm, estimated that Moderna's mRNA-3927 is set to generate $278 million in 2028. Moderna recently confirmed that its Phase I/II study of candidate mRNA-3927 is moving forward. It also revealed that data from mRNA-3927...

MSD pharma likely to participate when govt issues tender for vaccine against cervical cancer

MSD Pharmaceuticals is likely to participate in a global tender that the Union Health Ministry is likely to float in April to procure HPV vaccine against cervical cancer for immunisation of girls aged 9 to 14. MSD Pharmaceuticals Private Limited...

Aurobindo Pharma gets VAI classification from USFDA for Telangana plant

Aurobindo Pharma said it has received Voluntary Action Indicated (VAI) from the US health regulator for its Telangana-based manufacturing plant. As per the information available on the United States Food and Drug Administration (USFDA) website,...

Torrent Pharma enters the OTC market with a calcium supplement

Torrent Pharmaceuticals said it has forayed into the over-the-counter segment in the country with Shelcal 500, a calcium supplement brand. With its composition of 500mg Calcium and 250 IU of Vitamin D3, Shelcal 500 helps optimise calcium...

Herbalife Nutrition India enters eye health segment with Ocular Defense

Herbalife Nutrition India, a global nutrition firm, has entered the eye health segment with its new product, 'Ocular Defense,' in keeping with its commitment to nutrition and wellness...

NPPA urges pharma companies to register in IPDMS 2.0 to expedite the process of regulatory approvals

Dr Vinod Kotwal, Member Secretary, National Pharmaceuticals Pricing Authority (NPPA) has urged the Indian pharmaceutical companies to register in Integrated Pharmaceutical Database Management System (IPDMS 2.0) for making a robust database...

© 2025 India Pharma Outlook. All Rights Reserved.